Navigation Links
Consortium gets $7.2 million contract renewal to promote phase II clinical trials

TAMPA, Fla. -- The National Cancer Institute recently awarded $7.2 million for the competitive renewal of the Southeast Phase 2 Consortium (SEP2C), led by Moffitt Cancer Center's Daniel Sullivan, M.D., executive vice president and associate center director for Clinical Investigations. The renewal is through September 2016.

The SEP2C enrolls patients to phase II clinical trials and some phase I trials across six member sites. Moffitt is the lead site for the large contract that is awarded through the NCI's N01 research and development contract mechanism. The first year is projected to provide nearly $1.5 million.

The other member sites are UNC Lineberger Comprehensive Cancer; Vanderbilt-Ingram Cancer Center; Winship Cancer Institute of Emory University; VCU Massey Cancer Center; and the Cancer Institute of New Jersey.

Patient accrual at Moffitt will be focused on the following cancers: acute myeloid leukemia, breast, colorectal, lung, myelodysplastic syndrome, melanoma, multiple myeloma, non-Hodgkin's lymphoma, ovarian and sarcoma, as well as on immunotherapy and novel phase I trials. The consortium provides full management of the clinical trials including initiation, assessing eligibility, recruitment, evaluation of toxicity and response, auditing, follow-up, and analysis of results.

Contact: Ferdie DeVega
H. Lee Moffitt Cancer Center & Research Institute

Page: 1

Related medicine news :

1. Einstein researcher helps lead consortium for $10 million X Prize to sequence genomes of 100 centenarians
2. University of Delaware to lead DoD orthopaedic rehabilitation consortium
3. Hutchinson Center receives $8.2M to coordinate obesity and cancer consortium
4. BIDMC to co-lead NIH consortium for AIDS vaccine research in nonhuman primates
5. ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium
6. Scripps Translational Science Institute joins Jackson Laboratory tumor consortium
7. Consortium identifies genome regions that could influence severity of cystic fibrosis
8. Biodesign hosts international consortium on screening for lung cancer
9. LSTM leads new £6 million ($9.3 million) health systems knowledge consortium
10. International consortium to examine the impact of medical devices on health and retirement
11. NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer consortium
Post Your Comments:
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... 23, 2016 , , , ... 7, 2016 , , , , LOCATION: , , , ... , , , EXPERT PANELISTS:  , , , Frost & Sullivan,s ... Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program ... global pharmaceutical industry is witnessing an exceptional era. Several new demand ...
Breaking Medicine Technology: